Work

Abstract CT184: Phase 1/2 clinical trial of JIN-A02, a 4th generation EGFR-TKI in EGFR mutated advanced/metastatic non-small cell lung cancer

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-ct184

Authors: Sun Min Lim, Byoung Chul Cho, Ji Youn Han, Sang We Kim, Ki Hyeong Lee, Byoung Yong Shim, Jong-Mu Sun, Misako Nagasaka, Anna Jo, Ethan Seah, Choonok Kim, Thanyanan Reungwetwattana

Institutions: Yonsei University, National Cancer Center, Asan Medical Center, Chungbuk National University, Chungbuk National University Hospital, The Catholic University of Korea St. Vincent's Hospital, Samsung Medical Center, University of California, Irvine, J Ints Bio (South Korea), Mahidol University, Ramathibodi Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409822079

Cites:

Cited by:

Related to: 10